Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Marvell Technology, Inc. Director's Dealing 2022

Apr 20, 2022

29937_dirs_2022-04-19_f08c063d-9d3f-4fe2-8c91-6743a9abdb74.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Marvell Technology, Inc. (MRVL)
CIK: 0001835632
Period of Report: 2022-04-15

Reporting Person: Jarnac Dean E Jr. (EVP Worldwide Sales)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-04-15 Common Stock M 8858 $0.00 Acquired 61147 Direct
2022-04-15 Common Stock F 4392 $60.97 Disposed 56755 Direct
2022-04-15 Common Stock M 862 $0.00 Acquired 57617 Direct
2022-04-15 Common Stock F 428 $60.97 Disposed 57189 Direct
2022-04-15 Common Stock M 2320 $0.00 Acquired 59509 Direct
2022-04-15 Common Stock F 1151 $60.97 Disposed 58358 Direct
2022-04-15 Common Stock M 1384 $0.00 Acquired 59742 Direct
2022-04-15 Common Stock F 687 $60.97 Disposed 59055 Direct
2022-04-19 Common Stock S 6000 $60.96 Disposed 24879 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2022-04-15 Restricted Stock Units $ M 8858 Disposed Common Stock (8858) Direct
2022-04-15 Restricted Stock Units $ M 1384 Disposed Common Stock (1384) Direct
2022-04-15 Restricted Stock Units $ M 862 Disposed Common Stock (862) Direct
2022-04-15 Restricted Stock Units $ M 2320 Disposed Common Stock (2320) Direct
2022-04-15 Restricted Stock Units $ A 15746 Acquired Common Stock (15746) Direct

Footnotes

F1: Surrender of shares in payment of tax withholding due as a result of the vesting of restricted stock units ("RSUs").

F2: Each RSU represents a contingent right to receive one Marvell Technology, Inc. common share upon vesting.

F3: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F4: Shares are held in a revocable trust. Dean and Megan Jarnac are trustees of the trust, of which their children are the beneficiaries.

F5: Grant is fully vested.

F6: The remaining RSUs vest quarterly on each of 04/15/2022, 07/15/2022, 10/15/2022, 01/15/2023, 04/15/2023, 07/15/2023, 10/15/2023, 01/15/2024 and 04/15/2024.

F7: The remaining RSU's will vest on 07/15/2022, 10/15/2022, 01/15/2023 and 04/15/2023.

F8: The RSUs will vest in equal quarterly installments over three years, and were granted as part of the annual grant process.